KR20000029564A - 5ＨＴ2ｃ길항제및Ｄ2길항제를함유하는약제학적조성물 - Google Patents

5ＨＴ2ｃ길항제및Ｄ2길항제를함유하는약제학적조성물 Download PDF

Info

Publication number
KR20000029564A
KR20000029564A KR1019997000622A KR19997000622A KR20000029564A KR 20000029564 A KR20000029564 A KR 20000029564A KR 1019997000622 A KR1019997000622 A KR 1019997000622A KR 19997000622 A KR19997000622 A KR 19997000622A KR 20000029564 A KR20000029564 A KR 20000029564A
Authority
KR
South Korea
Prior art keywords
antagonist
5ht2c
pharmaceutically acceptable
pharmaceutical composition
compound
Prior art date
Application number
KR1019997000622A
Other languages
English (en)
Korean (ko)
Inventor
토마스 폴 블랙번
Original Assignee
피터 기딩스
스미스클라인비이참피이엘시이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 피터 기딩스, 스미스클라인비이참피이엘시이 filed Critical 피터 기딩스
Publication of KR20000029564A publication Critical patent/KR20000029564A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019997000622A 1996-07-26 1997-07-22 5ＨＴ2ｃ길항제및Ｄ2길항제를함유하는약제학적조성물 KR20000029564A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9615767.2A GB9615767D0 (en) 1996-07-26 1996-07-26 Novel treatment
GB9615767.2 1996-07-26

Publications (1)

Publication Number Publication Date
KR20000029564A true KR20000029564A (ko) 2000-05-25

Family

ID=10797573

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019997000622A KR20000029564A (ko) 1996-07-26 1997-07-22 5ＨＴ2ｃ길항제및Ｄ2길항제를함유하는약제학적조성물

Country Status (19)

Country Link
EP (1) EP0936924A2 (hu)
JP (1) JP2000516924A (hu)
KR (1) KR20000029564A (hu)
CN (1) CN1230894A (hu)
AR (1) AR008083A1 (hu)
AU (1) AU725817B2 (hu)
BR (1) BR9710568A (hu)
CA (1) CA2261813A1 (hu)
CO (1) CO5031292A1 (hu)
CZ (1) CZ23799A3 (hu)
GB (1) GB9615767D0 (hu)
HU (1) HUP9903619A3 (hu)
IL (1) IL128219A0 (hu)
NO (1) NO990322L (hu)
NZ (1) NZ333813A (hu)
PL (1) PL331426A1 (hu)
TR (1) TR199900140T2 (hu)
WO (1) WO1998004289A2 (hu)
ZA (1) ZA976593B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612883D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
US6174882B1 (en) 1998-11-23 2001-01-16 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
CA2351718A1 (en) 1998-11-23 2000-06-02 Sepracor Inc. Desmethylolanzapine compositions and methods
WO2000030649A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. Pharmaceutical compositions containing olanzapine-n-oxide
WO2000054764A2 (en) * 1999-03-18 2000-09-21 Children's Hospital Research Foundation A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
EP1223939A1 (en) * 1999-05-19 2002-07-24 AstraZeneca AB Method of treating weight gain
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500998D0 (sv) * 1995-03-19 1995-03-19 Haakan Wilhelm Wikstroem New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics

Also Published As

Publication number Publication date
ZA976593B (en) 1999-01-25
HUP9903619A2 (hu) 2000-10-28
HUP9903619A3 (en) 2001-03-28
NO990322L (no) 1999-03-24
PL331426A1 (en) 1999-07-19
WO1998004289A3 (en) 1998-03-19
EP0936924A2 (en) 1999-08-25
CN1230894A (zh) 1999-10-06
WO1998004289A2 (en) 1998-02-05
CZ23799A3 (cs) 1999-06-16
CA2261813A1 (en) 1998-02-05
IL128219A0 (en) 1999-11-30
NO990322D0 (no) 1999-01-25
BR9710568A (pt) 1999-08-17
NZ333813A (en) 2000-07-28
GB9615767D0 (en) 1996-09-04
AU4297297A (en) 1998-02-20
CO5031292A1 (es) 2001-04-27
TR199900140T2 (xx) 1999-03-22
JP2000516924A (ja) 2000-12-19
AU725817B2 (en) 2000-10-19
AR008083A1 (es) 1999-12-09

Similar Documents

Publication Publication Date Title
DE60122767T2 (de) Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns
KR0174752B1 (ko) 이환식 헤테로환 함유 술폰아미드 유도체 및 그 제조방법
RU2294932C2 (ru) Новые производные индола со сродством к рецептору 5-ht6
FI107158B (fi) Menetelmä kondensoitujen indolikarboksylaatti- ja indolikarboksiamidijohdannaisten valmistamiseksi
KR20050021494A (ko) 5-하이드록시트립타민-6 리간드로서의1-헤테로사이클릴알킬-3-설포닐인돌 또는 -인다졸 유도체
DE69105659T2 (de) 3-Arylindol- und 3-Arylindazolderivate.
KR0183396B1 (ko) 3-아릴카르보닐-1-아미노알킬-1h-인돌류,이를 함유하는 항녹내장 조성물 및 이의 제조방법
JPH09502177A (ja) ５ｈｔ１ｄレセプター拮抗薬用インドールおよびインドリン誘導体
EA029311B1 (ru) Hантагонисты, имеющие феноксипиперидиновое ядро в структуре, и их применение для лечения и/или профилактики состояний, опосредуемых hрецепторами
WO1997008167A1 (en) 5ht2c and 5ht2b antagonists
JP5062939B2 (ja) セロトニン受容体及びドーパミン受容体にアフィニティーを示す新規ｎ，ｎ’−二置換ベンゾイミダゾロン誘導体
AU2010340745B2 (en) Sulfone compounds as 5-HT6 receptor ligands
US6313145B1 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists
EP2114878A1 (en) 5-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands
AU3978899A (en) Serotonergic 5HT, receptor compounds for treating ocular and CNS disorders
KR20000029564A (ko) 5ＨＴ2ｃ길항제및Ｄ2길항제를함유하는약제학적조성물
JP2010515673A (ja) ４−（ヘテロシクリル）アルキル−ｎ−（アリールスルホニル）インドール化合物および５−ｈｔ６リガンドとしてのその使用
TW382015B (en) Pyridin-3-yloxy-pyridin- or pyridazin-3-ylcarbamoyl-indoline derivatives having 5HT2c receptor antagonist activity, a process for the preparation thereof, and a pharmaceutical composition comprising them
JPH03218356A (ja) トランス―４―アミノ（アルキル）―１―ピリジルカルバモイルシクロヘキサン化合物およびその医薬用途
JPH09512025A (ja) ５ｈｔ▲下２ｃ▼および５ｈｔ▲下２ｂ▼アンタゴニストとしての三環式誘導体
WO2022161166A1 (zh) 靶向嵌合化合物、含其的药物组合物及其制备方法和用途
KR840002139B1 (ko) 벤조퀴놀리진의 제조방법
JP2001526674A (ja) ５ｈｔ２ｃ受容体アンタゴニストとしてのインドリン誘導体
RU2127732C1 (ru) Эфиры бис-фенилпиперазинникотиновой кислоты, способ их получения (варианты), фармацевтическая композиция и способ лечения расстройств центральной нервной системы
JPH10152470A (ja) ピペラジン化合物

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid